You are here

Australian State & Territory variations from Part 4 of the Poisons Standard

Scheduling medicines & poisons

31 May 2019

Part 4 of the Standard for the Uniform Scheduling of Medicines and Poisons (scheduled to the current Poisons Standard) is a record of decisions regarding the classification of medicines and chemicals into Schedules. States and territories can adopt the current Poisons Standard as made or adopt it subject to variations. Variations in each state and territory from Part 4 of the Poisons Standard are summarised below.

Note: The information below is current as at 9 October 2018 and will be updated annually. You should refer to state and territory legislation within the relevant jurisdiction to determine whether the information below remains current.

Australian Capital Territory

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
Exemption for piper methysticum (kava) if prepared, possessed and consumed in accordance with the customs of the Pacific Islands in connection with an event declared by the Minister as per section 864 Medicines, Poisons and Therapeutic Goods Regulation 2008. Recognition of the cultural importance of kava to people of Pacific Island origin. Further details may be accessed at ACT HealthMedicines, Poisons and Therapeutic Goods Regulation 2008 or Pharmaceutical Services.

New South Wales

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Northern Territory

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Queensland

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

South Australia

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
No variations

Tasmania

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
Tasmania has made the Poisons (Application of Uniform Standard) Order 2018.  This reclassifies Cannabis Sativa from Schedule 9 to Schedule 8 when used for the scientific research or development of products for human therapeutic use by the holder of a Tasmanian manufacturing or research licence.

The proposed change will allow licences to be issued to permit, under strict conditions, defined testing or analysis on Cannabis Sativa as a Schedule 8 substance in Tasmania for scientific purposes.

The change will allow wholesale chemists to supply Cannabis Sativa reference standards and permit possession and use of Cannabis Sativa for scientific research and development purposes under licence only.

Victoria

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers

No variations

Western Australia

See Medicines and Poisons Act 2014

Departure from Part 4 of the Poisons Standard Justification Effect on suppliers or consumers
Addition to Schedule 4 of SCAEVOLA SPINESCENS. To limit use of an extract of the plant for the treatment of cancer. Must be supplied as a prescription medicine.